Cell
Volume 77, Issue 4, 20 May 1994, Pages 491-502
Journal home page for Cell

Article
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

https://doi.org/10.1016/0092-8674(94)90212-7Get rights and content

Abstract

We have generated mice homozygous for a disruption of the mdr1a (also called mdr3) gene, encoding a drug-transporting P-glycoprotein. The mice were viable and fertile and appeared phenotypically normal, but they displayed an increased sensitivity to the centrally neurotoxic pesticide Ivermectin (100-fold) and to the carcinostatic drug vinblastine (3-fold). By comparison of mdr1a (+/+) and (−/−) mice, we found that the mdr1a P-glycoprotein is the major P-glycoprotein in the blood-brain barrier and that its absence results in elevated drug levels in many tissues (especially in brain) and in decreased drug elimination. Our findings explain some of the side effects in patients treated with a combination of carcinostatics and P-glycoprotein inhibitors and indicate that these inhibitors might be useful in selectively enhancing the access of a range of drugs to the brain.

References (58)

  • K. Ueda et al.

    Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone

    J. Biol. Chem.

    (1992)
  • A.M. van der Bliek et al.

    Sequence of mdr3 cDNA encoding a human P-glycoprotein

    Gene

    (1988)
  • N. van der Lugt et al.

    A pgk::hprt fusion as a selectable marker for targeting of genes in mouse embryonic stem cells: disruption of the T-cell receptor δ-chain-encoding gene

    Gene

    (1991)
  • B.N. Ames et al.

    Nature's chemicals and synthetic chemicals: comparative toxicology

  • R.J. Arceci et al.

    The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus

  • A. Bradley

    Production and analysis of chimeric mice

  • G. Bradley et al.

    Sex-dependent and independent expression of the P-glycoprotein isoforms in Chinese hamster

    J. Cell. Physiol.

    (1990)
  • W.B. Bradbury

    The blood-brain barrier: transport across the cerebral endothelium

    Circ. Res.

    (1985)
  • W.C. Campbell

    Ivermectin and Abamectin

    (1989)
  • W.T. Cefalu et al.

    Restrictive transport of a lipid-soluble peptide (cyclosporin) through the blood-brain barrier

    J. Neurochem

    (1985)
  • H.S.L. Chan et al.

    P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma

    N. Engl. J. Med.

    (1991)
  • C. Cordon-Cardo et al.

    Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

  • J.M. Croop et al.

    The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissue

    Mol. Cell. Biol.

    (1989)
  • A. Devault et al.

    Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities

    Mol. Cell. Biol.

    (1990)
  • J.A. Endicott et al.

    The biochemistry of P-glycoprotein-mediated multidrug resistance

    Annu. Rev. Biochem.

    (1989)
  • M.H. Fisher et al.

    The chemistry and pharmacology of avermectins

    Annu. Rev. Pharmacol. Toxicol.

    (1992)
  • J.M. Ford et al.

    Pharmacology of drugs that alter multidrug resistance in cancer

    Pharmacol. Rev.

    (1990)
  • E. Georges et al.

    Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies

  • G.W. Goldstein et al.

    The blood-brain barrier

    Sci. Am.

    (1986)
  • Cited by (2139)

    View all citing articles on Scopus
    View full text